Use of interleukin-19 to treat cervical cancer
AssigneeZymoGenetics, Inc.
InventorsYasmin A. Chandrasekher, Patricia A. McKernan
Life of this patent
Estimating the term…
Abstract
The present invention relates to the anti-cancer activity of IL-19 polypeptide molecules. IL-19 is a cytokine involved in inflammatory processes and human disease. The present invention includes Use of IL-19 for decreasing proliferation of cervical cancer cells, treating cervical cancer, amongst other uses disclosed. IL-19 polypeptides can be administered alone, or can be fused to cytotoxic moieties, and can be administered in conjunction with radiation or chemotherapeutic agents.
Claims1
A method for inhibiting the growth and or proliferation of cervical cancer cells in vitro comprising bringing IL-19 polypeptide into contact with the cervical cancer cells in an amount sufficient to inhibit or reduce the proliferation of the cervical cancer cells.
Dependencies are inferred from the claim text.